| Bioactivity | AMG133 peptide payload TFA is the TFA salt form of AMG133 peptide payload (HY-P10736). AMG133 peptide payload TFA is a GLP-1 agonist that can be used for synthesis of AMG133 (HY-164535) as a peptide linker conjugate[1]. | ||||||
| Shortening | H[Aib]EGTFTSDYSSYLEEQAAKEFIAWLVKGGG(GGGGS)3 K(BrAc){CONH2} | ||||||
| Formula | C196H290BrN55O69.xC2HF3O2 | ||||||
| Molar Mass | 4600.70 (free base) | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. Véniant MM, et al. A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings. Nat Metab. 2024 Feb;6(2):290-303. |
AMG133 peptide payload TFA
CAS: F: C196H290BrN55O69.xC2HF3O2 W: 4600.70 (free base)
AMG133 peptide payload TFA is the TFA salt form of AMG133 peptide payload (HY-P10736). AMG133 peptide payload TFA is a G
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.